RIVFLOZA Trademark

Trademark Overview

On Tuesday, February 21, 2023, a trademark application was filed for RIVFLOZA with the United States Patent and Trademark Office. The USPTO has given the RIVFLOZA trademark a serial number of 79365572. The federal status of this trademark filing is REGISTERED as of Tuesday, March 12, 2024. This trademark is owned by NOVO NORDISK HEALTH CARE AG. The RIVFLOZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment of kidney diseases and for treatment of liver diseases, pharmaceutical preparations for treatment of primary hyperoxaluria
rivfloza

General Information

Serial Number79365572
Word MarkRIVFLOZA
Filing DateTuesday, February 21, 2023
Status700 - REGISTERED
Status DateTuesday, March 12, 2024
Registration Number7324598
Registration DateTuesday, March 12, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 26, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for treatment of kidney diseases and for treatment of liver diseases, pharmaceutical preparations for treatment of primary hyperoxaluria

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 20, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOVO NORDISK HEALTH CARE AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameNOVO NORDISK HEALTH CARE AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameNOVO NORDISK HEALTH CARE AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events

Event DateEvent Description
Friday, March 17, 2023SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Monday, March 20, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 24, 2023APPLICATION FILING RECEIPT MAILED
Wednesday, August 2, 2023ASSIGNED TO EXAMINER
Wednesday, August 2, 2023NON-FINAL ACTION WRITTEN
Thursday, August 3, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, August 25, 2023REFUSAL PROCESSED BY MPU
Friday, August 25, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, September 17, 2023REFUSAL PROCESSED BY IB
Thursday, October 12, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 12, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 12, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 12, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 12, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, October 12, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 27, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 27, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 27, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 31, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 14, 2023WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, December 6, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 6, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 6, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, December 26, 2023NOTIFICATION PROCESSED BY IB
Tuesday, December 26, 2023PUBLISHED FOR OPPOSITION
Tuesday, December 26, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, March 12, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, June 13, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sunday, July 21, 2024FINAL DISPOSITION NOTICE SENT TO IB
Sunday, August 11, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Sunday, July 21, 2024FINAL DISPOSITION PROCESSED

Related Keywords

rivfloza treatment diseases preparations pharmaceutical hyperoxaluria primary kidney liver